[
  {
    "url": "https://www.cancer.gov/types/cervical/survival",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/cervical/treatment",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/cervical/treatment/by-stage",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/cervical/treatment/cancer-treatment-during-pregnancy",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/cervical/coping",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/bladder",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/bladder/causes-risk-factors",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/bladder/symptoms",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/bladder/screening",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/bladder/diagnosis",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/bladder/survival",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/bladder/stages",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/bladder/treatment",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/bladder/childhood",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/bladder/treatment/by-stage",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/bladder/coping",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/pdq/information-summaries/genetics/brca-genes-hp-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/cervical/childhood-cervical-vaginal-cancer",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/lymphoma/hp/indolent-b-cell-lymphoma-treatment-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/lymphoma/hp/peripheral-t-cell-lymphoma-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/lymphoma/hp/non-hodgkin-lymphoma-treatment-during-pregnancy-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/stomach/hp/gastric-genetics-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/pdq/information-summaries/genetics/hereditary-diffuse-gastric-cancer-hp-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/pdq/information-summaries/genetics/runx1-hp-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/pdq/information-summaries/genetics/cebpa-hp-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/pdq/information-summaries/genetics/ddx41-hp-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/brain/patient/childhood-ependymoma",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/brain/patient/diffuse-intrinsic-pontine-glioma",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/brain/patient/childhood-glioma-astrocytoma",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/leukemia/hp/child-aml-treatment-pdq/childhood-apl-treatment-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/leukemia/hp/child-aml-treatment-pdq/myeloid-proliferations-down-syndrome-treatment-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/leukemia/hp/child-aml-treatment-pdq/myeloid-dysplastic-neoplasms-treatment-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/leukemia/hp/child-aml-treatment-pdq/childhood-jmml-treatment-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/leukemia/hp/child-aml-treatment-pdq/childhood-cml-treatment-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/pdq/information-summaries/genetics/rtps1-hp-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/pdq/information-summaries/genetics/gapps-hp-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/types/agnostic-cancer-therapies-hp-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/side-effects/cancer-symptom-clusters-hp-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/pdq/information-summaries/genetics/hereditary-hematologic-malignancies",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/pdq/information-summaries/genetics/gata2",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/pdq/information-summaries/genetics/mbd4-hp-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/pdq/information-summaries/genetics/palb2-hp-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/pdq/information-summaries/genetics/men2-hp-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/lymphoma/hp/hodgkin-lymphoma-treatment-during-pregnancy-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/lymphoma/hp/aggressive-b-cell-lymphoma-treatment-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/pdq/information-summaries/genetics/rtps2-hp-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/cervical/hp/treatment-during-pregnancy-pdq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/lymphoma/hp/mantle-cell-lymphoma-treatment",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/types/kidney/patient/childhood-kidney-cancer",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/imatinibmesylate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/pemetrexeddisodium",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/bevacizumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/bortezomib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/cetuximab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/fulvestrant",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/sunitinibmalate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/exemestane",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/nelarabine",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/sorafenibtosylate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/erlotinibhydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/clofarabine",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/oxaliplatin",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/palifermin",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/lenalidomide",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/nanoparticlepaclitaxel",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/imiquimod",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/decitabine",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/letrozole",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/gemcitabinehydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/topotecanhydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/gefitinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/rituximab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/talc",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/dasatinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/azacitidine",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/capecitabine",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/docetaxel",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/temozolomide",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/thalidomide",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/aminolevulinicacid",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/aprepitant",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/arsenictrioxide",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/bexarotene",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/epirubicinhydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/paclitaxel",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/trastuzumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/tamoxifencitrate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/gemtuzumabozogamicin",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/palonosetronhydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/zoledronicacid",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/pegaspargase",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/panitumumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/vorinostat",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/anastrozole",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/cisplatin",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/irinotecanhydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/fluorouracil",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/lapatinibditosylate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/cytarabine",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/doxorubicinhydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/doxorubicin-hydrochloride-liposome",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/temsirolimus",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/carboplatin",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/raloxifenehydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/cyclophosphamide",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ibritumomabtiuxetan",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/dexrazoxanehydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/alemtuzumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ixabepilone",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/nilotinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/methotrexate-sodium",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/leuprolideacetate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/etoposide",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/etoposidephosphate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/bendamustinehydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/aldesleukin",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/fludarabinephosphate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/leucovorincalcium",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/vincristinesulfate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/romiplostim",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/cmf",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/bleomycin",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/eltrombopagolamine",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/plerixafor",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ac-t",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/degarelix",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/abvd",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/beacopp",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/caf",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/gemcitabine-cisplatin",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/chop",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/epoch",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ice",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/mopp",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/r-chop",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/stanfordv",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/folfox",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/folfiri",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/everolimus",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/filgrastim",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/daunorubicinhydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/dacarbazine",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/toremifene",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/prednisone",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/pralatrexate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ofatumumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/pazopanibhydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/rasburicase",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/recombinant-hpv-bivalent-vaccine",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/recombinant-hpv-quadrivalent-vaccine",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/romidepsin",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/denileukindiftitox-cxdl",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ac",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/sipuleucel-t",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/procarbazinehydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/cabazitaxel",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/abve",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ade",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/bep",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/chlorambucil",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/abve-pc",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ifosfamide",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/copp",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/chlorambucil-prednisone",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/eribulinmesylate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/denosumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/vinblastinesulfate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ipilimumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/vandetanib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/abirateroneacetate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/vinorelbinetartrate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/mesna",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/cvp",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/fec",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/folfiri-bevacizumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/fu-lv",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/vemurafenib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/brentuximabvedotin",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/mechlorethaminehydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/crizotinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/mitomycin",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/folfirinox",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/r-cvp",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ruxolitinibphosphate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/asparaginase-erwinia-chrysanthemi",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/vamp",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/veip",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/xelox",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/axitinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/glucarpidase",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/lomustine",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/dactinomycin",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/vismodegib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/capox",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/carboplatin-taxol",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/pertuzumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ziv-aflibercept",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/carfilzomib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/bosutinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/enzalutamide",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/regorafenib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/omacetaxinemepesuccinate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/cabozantinib-s-malate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ponatinibhydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/pomalidomide",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/folfiri-cetuximab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/recombinant-interferon-alfa-2b",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ado-trastuzumab-emtansine",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/megestrolacetate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/radium-223-dichloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/copp-abv",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/dabrafenib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/trametinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/mercaptopurine",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/afatinibdimaleate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/pamidronatedisodium",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/oppa",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/gemcitabine-oxaliplatin",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/oepa",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/obinutuzumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/goserelinacetate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/tac",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ibrutinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/bicalutamide",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/busulfan",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/hyper-cvad",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/siltuximab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ramucirumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ceritinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/off",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/pad",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/carmustine",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/carmustineimplant",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/belinostat",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/idelalisib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/tpf",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/mitoxantronehydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/pembrolizumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/idarubicinhydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/vip",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/thiotepa",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/xeliri",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/recombinant-hpv-nonavalent-vaccine",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/lanreotideacetate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/olaparib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/nivolumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/palbociclib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/lenvatinibmesylate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/r-epoch",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/dinutuximab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/netupitant-palonosetronhydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ondansetronhydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/sonidegib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/dexamethasone",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/thioguanine",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/pcv",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/copdac",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/rolapitanthydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/trifluridine-tipiracilhydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/irinotecan-hydrochloride-liposome",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/trabectedin",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/talimogenelaherparepvec",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/cobimetinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/osimertinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/daratumumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ixazomibcitrate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/necitumumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/vac",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/elotuzumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/alectinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/flutamide",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/uridinetriacetate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/fluorouracil-topical",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/cem",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/melphalan-hydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/melphalan",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/defibrotide-sodium",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/venetoclax",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/hydroxyurea",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/atezolizumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/bumel",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/peb",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/r-ice",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/propranolol-hydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/jeb",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/nilutamide",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/cev",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/cladribine",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/pegfilgrastim",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/rucaparibcamsylate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/methylnaltrexonebromide",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/amifostine",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ribociclib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/avelumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/niraparibtosylatemonohydrate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/durvalumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/brigatinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/midostaurin",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/neratinibmaleate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/enasidenibmesylate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/rituximabandhyaluronidasehuman",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/inotuzumabozogamicin",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/tisagenlecleucel",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/daunorubicinhydrochlorideandcytarabineliposome",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/abemaciclib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/axicabtageneciloleucel",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/valrubicin",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/acalabrutinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/lutetiumlu177-dotatate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/apalutamide",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/tocilizumab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/darbepoetinalfa",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/epoetinalfa",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/fostamatinibdisodium",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/encorafenib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/binimetinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ivosidenib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/granisetronhydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/granisetron",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/mvac",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/iobenguanei131",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/mogamulizumabkpkc",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/cemiplimab-rwlc",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/dacomitinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/duvelisib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/larotrectinibsulfate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/lorlatinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/glasdegibmaleate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ravulizumab-cwvz",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/emapalumab-lzsg",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/gilteritinibfumarate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/tagraxofusp-erzs",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/calaspargasepegol-mknl",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/caplacizumab-yhdp",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/talazoparibtosylate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/trastuzumabandhyaluronidase-oysk",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/erdafitinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/alpelisib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/polatuzumabvedotin-piiq",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/darolutamide",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/selinexor",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/fedratinibhydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/entrectinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/zanubrutinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/famtrastuzumabderuxtecan-nxki",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/avapritinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/enfortumabvedotin-ejfv",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/tazemetostathydrobromide",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/isatuximab-irfc",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/pexidartinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/selumetinibsulfate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/pemigatinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/tucatinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/sacituzumabgovitecan-hziy",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/luspatercept-aamt",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/daratumumabandhyaluronidase-fihj",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/selpercatinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ripretinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/capmatinibhydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/lurbinectedin",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/pertuzumabtrastuzumabandhyaluronidase-zzxf",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/decitabineandcedazuridine",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/tafasitamab-cxix",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/brexucabtageneautoleucel",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/pralsetinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/relugolix",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/naxitamab-gqgk",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/margetuximab-cmkb",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/lisocabtagenemaraleucel",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/tepotinibhydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/tivozanibhydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/idecabtagenevicleucel",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/loncastuximabtesirine-lpyl",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/dostarlimab-gxly",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/sotorasib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/amivantamab-vmjw",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/asparaginase-erwinia-chrysanthemi-recombinant",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/belzutifan",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/tisotumabvedotin-tftv",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/asciminib-hydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ropeginterferon-alfa-2b-njft",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/sirolimus-protein-bound-particles",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/tebentafusp-tebn",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/pacritinib-citrate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ciltacabtagene-autoleucel",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/nivolumab-and-relatlimab-rmbw",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/lutetium-lu-177-vipivotide-tetraxetan",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/futibatinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/tremelimumab-actl",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/teclistamab-cqyv",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/olutasidenib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/mirvetuximab-soravtansine-gynx",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/adagrasib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/nadofaragene-firadenovec-vncg",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/elacestrant-dihydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/pirtobrutinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/mosunetuzumab-axgb",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/blinatumomab",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/retifanlimab-dlwr",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/epcoritamab-bysp",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/quizartinib-dihydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/glofitamab-gxbm",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/niraparib-tosylate-monohydrate-and-abiraterone-acetate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/elranatamab-bcmm",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/talquetamab-tgvs",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/momelotinib-dihydrochloride-monohydrate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/fruquintinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/repotrectinib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/toripalimab-tpzi",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/capivasertib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/nirogacestat",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/eflornithine-hydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/lifileucel",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/tislelizumab-jsgr",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/tovorafenib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/nogapendekin-alfa-inbakicept-pmln",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/tarlatamab-dlle",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/imetelstat-sodium",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/leuprolide-mesylate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/afamitresgene-autoleucel",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/vorasidenib-citrate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/lazertinib-mesylate-hydrate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/triptorelin-pamoate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ribociclib-succinate-and-letrozole",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/atezolizumab-and-hyaluronidase-tqjs",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/inavolisib",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/zolbetuximab-clzb",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/revumenib-citrate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/obecabtagene-autoleucel",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/zanidatamab-hrii",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/datopotamab-deruxtecan-dlnk",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/zenocutuzumab-zbco",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/cosibelimab-ipdl",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/ensartinib-hydrochloride",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/nivolumab-and-hyaluronidase-nvhy",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/treosulfan",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/vimseltinib-dihydrate",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/about-cancer/treatment/drugs/penpulimab-kcqx",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/dictionaries/cancer-terms/def/coping-skills",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/dictionaries/cancer-terms/def/survivorship",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/dictionaries/cancer-terms/def/survivorship-care-plan",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/dictionaries/cancer-terms/def/treatment-cycle",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/dictionaries/cancer-terms/def/treatment-plan",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/dictionaries/cancer-terms/def/treatment-schedule",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/publications/dictionaries/cancer-terms/def/treatment-summary",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/rare-brain-spine-tumor/living/coping/find-support-video",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/pediatric-adult-rare-tumor/support/patients-caregivers/copingwithcovid19",
    "source": "sitemap"
  },
  {
    "url": "https://www.cancer.gov/pediatric-adult-rare-tumor/support/coping-young-adults",
    "source": "sitemap"
  }
]